Literature DB >> 21450947

Recruitment of cyclin-dependent kinase 9 to nuclear compartments during cytomegalovirus late replication: importance of an interaction between viral pUL69 and cyclin T1.

Sabine Feichtinger1, Thomas Stamminger1, Regina Müller1, Laura Graf1, Bert Klebl2, Jan Eickhoff2, Manfred Marschall1.   

Abstract

Cyclin-dependent protein kinases (CDKs) are important regulators of cellular processes and are functionally integrated into the replication of human cytomegalovirus (HCMV). Recently, a regulatory impact of CDK activity on the viral mRNA export factor pUL69 was shown. Here, specific aspects of the mode of interaction between CDK9/cyclin T1 and pUL69 are described. Intracellular localization was studied in the presence of a novel selective CDK9 inhibitor, R22, which exerts anti-cytomegaloviral activity in vitro. A pronounced R22-induced formation of nuclear speckled aggregation of pUL69 was demonstrated. Multi-labelling confocal laser-scanning microscopy revealed that CDK9 and cyclin T1 co-localized perfectly with pUL69 in individual speckles. The effects were similar to those described recently for the broad CDK inhibitor roscovitine. Co-immunoprecipitation and yeast two-hybrid analyses showed that cyclin T1 interacted with both CDK9 and pUL69. The interaction region of pUL69 for cyclin T1 could be attributed to aa 269-487. Moreover, another component of CDK inhibitor-induced speckled aggregates was identified with RNA polymerase II, supporting earlier reports that strongly suggested an association of pUL69 with transcription complexes. Interestingly, when using a UL69-deleted recombinant HCMV, no speckled aggregates were formed by CDK inhibitor treatment. This indicated that pUL69 is the defining component of aggregates and generally may represent a crucial viral interactor of cyclin T1. In conclusion, these data emphasize that HCMV inter-regulation with CDK9/cyclin T1 is at least partly based on a pUL69-cylin T1 interaction, thus contributing to the importance of CDK9 for HCMV replication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450947     DOI: 10.1099/vir.0.030494-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations.

Authors:  Corina Hutterer; Jan Eickhoff; Jens Milbradt; Klaus Korn; Isabel Zeitträger; Hanife Bahsi; Sabrina Wagner; Gunther Zischinsky; Alexander Wolf; Carsten Degenhart; Anke Unger; Matthias Baumann; Bert Klebl; Manfred Marschall
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

2.  Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44.

Authors:  Laurie A Silva; Blair L Strang; Eric W Lin; Jeremy P Kamil; Donald M Coen
Journal:  Virology       Date:  2011-07-23       Impact factor: 3.616

3.  Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression.

Authors:  Zsolt Toth; Kevin F Brulois; Lai-Yee Wong; Hye-Ra Lee; Brian Chung; Jae U Jung
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

4.  CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.

Authors:  Makoto Yamamoto; Hiroshi Onogi; Isao Kii; Suguru Yoshida; Kei Iida; Hiroyuki Sakai; Minako Abe; Toshiaki Tsubota; Nobutoshi Ito; Takamitsu Hosoya; Masatoshi Hagiwara
Journal:  J Clin Invest       Date:  2014-07-08       Impact factor: 14.808

5.  Inhibition of cdk9 during herpes simplex virus 1 infection impedes viral transcription.

Authors:  Mark Ou; Rozanne M Sandri-Goldin
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

6.  The Interaction between Cyclin B1 and Cytomegalovirus Protein Kinase pUL97 is Determined by an Active Kinase Domain.

Authors:  Mirjam Steingruber; Eileen Socher; Corina Hutterer; Rike Webel; Tim Bergbrede; Tihana Lenac; Heinrich Sticht; Manfred Marschall
Journal:  Viruses       Date:  2015-08-11       Impact factor: 5.048

7.  The cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclins.

Authors:  Laura Graf; Rike Webel; Sabrina Wagner; Stuart T Hamilton; William D Rawlinson; Heinrich Sticht; Manfred Marschall
Journal:  Viruses       Date:  2013-12-18       Impact factor: 5.048

Review 8.  P-TEFb goes viral.

Authors:  Justyna Zaborowska; Nur F Isa; Shona Murphy
Journal:  Inside Cell       Date:  2015-11-25

9.  Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins.

Authors:  Mirjam Steingruber; Alexandra Kraut; Eileen Socher; Heinrich Sticht; Anna Reichel; Thomas Stamminger; Bushra Amin; Yohann Couté; Corina Hutterer; Manfred Marschall
Journal:  Viruses       Date:  2016-08-18       Impact factor: 5.048

Review 10.  The Cytomegalovirus Protein Kinase pUL97:Host Interactions, Regulatory Mechanisms and Antiviral Drug Targeting.

Authors:  Mirjam Steingruber; Manfred Marschall
Journal:  Microorganisms       Date:  2020-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.